anti-CD19/BCMA-UCAR-T cells
2026-SR-020
Unknown mab active
Quick answer
anti-CD19/BCMA-UCAR-T cells for Rheumatoid Arthritis is a Unknown program (mab) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Rheumatoid Arthritis
- Phase
- Unknown
- Modality
- mab
- Status
- active